New Estimate Suggests Just 1 in 4 Americans Exposed to COVID-19 as of January
A new report, based on data from dialysis centers, suggests the US is far from reaching so-called “herd immunity.”
Effectiveness of Pfizer, AstraZeneca COVID-19 Vaccines Against Delta Variant
While a significantly reduced effectiveness was seen with 1 dose, only a small reduction was observed after 2.
How Does Adherence of Daily Dosing vs Event-Driven PrEP Regimens Compare?
Adherence for daily dosing decreased and event-driven PrEP usage increased in a Chinese study.
Resilience in People Living With HIV During the COVID-19 Pandemic
Impaired resilience was found to be associated with loneliness.
Providing Online HIV Services During the COVID-19 Pandemic
Virtual support services were crucial for providing continued care and education.
Screening for Potential PrEP Users at Retail Pharmacies
In a pilot project, customers were surveyed about HIV risk behaviors to gain further insights and assessed for potential PrEP utilization.
Addressing Antimicrobial Use in Nursing Home Residents
A research team working across several nursing homes sought to reduce antimicrobial use.
PrEP Use Low Among Individuals With Self-Reported HIV Risk Factors
Many respondents reported having a lack of information about the use of PrEP.
Those With HIV Have High Rates of COVID-19 Hospitalizations, Mortality
PLWH should strictly maintain ART therapy and COVID-19 mitigation efforts.
Promoting HIV Partner Notification Services Using a People-Centered Approach
Crowdsourcing and other approaches may develop more effective interventions to promote PS.
Exploring PrEP Implementation Factors in the Southern US
More tailored strategies could improve PrEP provision in family planning clinics.
Majority of PrEP Users Do Not Maintain Adherence
A meta-analysis study found that 70% of PrEP users either stopped or had inadequate adherence within 6 months of initiation.
Public Health Watch: Enhanced Monitoring for Hepatitis B Among Liver Transplant Patients May Be Needed
CDC report chronicles 20 incidents of HBV infection among recipients between 2014 and 2019.
FDA Approves Sleeping Sickness Therapy
The federal agency gives nod for fexinidazole as the first all-oral treatment for the parasitic illness.
The COVID-19 Pandemic and Resumption of PrEP Therapy
Small survey from gay and bisexual men (GBM) inquired about their experiences during COVID-19 restrictions, and feedback on PrEP.
CDC Confirms Case of Human Monkeypox in US Resident
The case was identified in an individual who had recently returned from a trip to Nigeria.
Impact of Home-Based Testing on Uptake and Knowledge of HIV Status
No significant difference was observed across the 3 study groups.
COVID-19 Humoral and T-Cell Immune Responses Among People Living With HIV
A positive relationship may exist between infection severity and adaptive immunity.
Outreach for PrEP Counseling Shows Ability to Reach Underserved Communities
In Brazil, a concerted effort of recruiting adolescents was made to go out and talk with them about PrEP.
Do Adverse Childhood Experiences Impact PrEP Uptake in Young Adulthood?
Rates of testing for HIV, as well as PrEP uptake, remain suboptimal in MSM of color.
Mortality of People Entering HIV Care Drops, Nearing That of General Population
US residents with HIV have higher rates of mortality than their peers without infection, but the gap is narrowing, a recent study showed.
Offering Market Incentives to Address Antimicrobial Resistance
The Pasteur Act in Congress is designed to incentivize pharmaceutical companies to develop new antibiotics.
Understanding PrEP Preferences in a Select Population
Investigators surveyed men who have sex with men (MSM) about long-acting injectable pre-exposure prophylaxis (PrEP) including attitudes towards potentially taking it and barriers to usage.
HIV Testing, Positive Results Dropped in the US During COVID-19
The pandemic's effect on in-person care prioritization may have indirectly influenced the rate of screening opportunities in at-risk persons.
Cabotegravir Plus Rilpivirine Well-Received by HIV Care Staff, Patients at 12 Months
New findings from CUSTOMIZE suggest the once-monthly injection therapy was feasibly implemented and generally favored to once-daily tablets.
Study: Homeless Persons with HIV Prefer Flexible Care Models, No Telehealth
Perspective gained from persons treated a real-world clinic may help better inform strategies to treat an HIV population that often struggles with viral suppression and consistent care.
COVID-19 Severe Risks Not Significant in People with HIV
A new study from IAS 2021 suggests persons with HIV hospitalized for COVID-19 do not face worse mortality nor major cardiovascular event risk.
Those at High Risk Know about PrEP but Use Remains low
Results from the study highlight the importance of PrEP education in clinical settings.
FDA Approves Pneumococcal 15-Valent Conjugate Vaccine for US Adults
The prophylaxis showed non-inferiority across shared serotypes with an available 13-valent vaccine in its indication-supporting data.
FDA Grants Priority Review to Pfizer-BioNTech COVID-19 Vaccine
The designation moves the companies' PDUFA date up to January 2022, when BNT162b2 may become the first regulated COVID-19 vaccine.
